Pharming (PHAR) Net Income Growth (1y) (2021 - 2026)
Pharming (PHAR) Net Income Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - | -0.46% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.85 Bn | 467.06 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.04 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.28 Bn | 3.31 Bn | -10.08% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | 63.48% |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.47 Bn | 959.66 Mn | 1,228.66% |
| 10 | Pharming | 8.96 Bn | 8.91 Bn | 65.80 Mn | -243.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -243.61% |
| Dec 31, 2025 | 300.47% |
| Sep 30, 2025 | -100.00% |
| Jun 30, 2025 | 125.07% |
| Mar 31, 2025 | 174.23% |
| Dec 31, 2024 | 61.84% |
| Sep 30, 2024 | -51.94% |
| Jun 30, 2024 | -43.12% |
| Mar 31, 2024 | 76.96% |
| Dec 31, 2023 | -135.56% |
| Sep 30, 2023 | -66.84% |
| Jun 30, 2023 | -172.67% |
| Mar 31, 2023 | -603.58% |
| Dec 31, 2022 | 149.53% |
| Sep 30, 2022 | 153.35% |
| Jun 30, 2022 | 76.60% |
| Mar 31, 2022 | -66.04% |
| Dec 31, 2021 | 256.10% |
| Sep 30, 2021 | 40.09% |